DPS - Dr Pepper Snapple Group, Inc.

YHD - YHD Delayed Price. Currency in USD
At close: 6:07PM EDT
Stock chart is not supported by your current browser
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (3Y Monthly)N/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • Moody's5 months ago

    Keurig Dr Pepper -- Moody's announces completion of a periodic review of ratings of Keurig Dr Pepper

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Keurig Dr Pepper and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

  • Investopedialast year

    Pfizer: 7 Secrets You Didn't Know (PFE)

    Pfizer Inc. (NYSE: PFE) is the world's 44th-largest public company, according to  Forbes. As of July 31, 2018, Pfizer had a market capitalization of $225.7 billion. Pfizer's roots date back to 1849, when two German-American entrepreneurs opened the company as a fine chemicals business, and it grew into a world-leading pharmaceuticals company that manufactures, markets, and distributes over 200 drugs in the United States.

  • We're sorry this is all we were able to find about this topic.